UK Diabetes Devices Market – Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2030
Overview
The UK Diabetes Devices Market size was valued at USD 800 Million in 2023 and the total UK Diabetes Devices revenue is expected to grow at a CAGR of 5.96% from 2024 to 2030, reaching nearly USD 1200 Million.
UK Diabetes Devices Market Overview-
This report analyses the UK Diabetes Devices market and covers anticipated trends, technological advancements, and potential disruptions that shape the market. It assesses market size, growth, economic factors, regulations, and commercial drivers. The competitive landscape is analyzed, highlighting differentiation among key operators and drawing on historical data and industry insights and the report forecasts sector. The economic downturn prompted this analysis and revealed the UK diabetes devices industry resilience challenges. Factors such as the prevalence of diabetes and environmental concerns drive increased awareness and improved diagnostic methods, a growing diabetes population, and a Sustainability focus. The report aims to equip stakeholders with crucial, concise information for informed decision-making in this dynamic sector. The targeted audiences include People with diabetes, Healthcare professionals, Secondary Audiences, Government agencies, policymakers, and pharmaceutical companies in the UK diabetes devices industry.
To know about the Research Methodology :- Request Free Sample Report
Increasing Diabetes Prevalence Impact on the UK Diabetes Devices Market
The increasing diabetes patient population drives demand for self-monitoring and insulin delivery devices and increases the UK Diabetes Devices market revenue. A diverse patient's needs from newly diagnosed to long-term complications and varying diabetes types, create opportunities for position players and device innovation, fostering UK Diabetes Devices industry growth and adaptation to specific requirements. The growing prevalence of diabetes prompts increased healthcare expenditure, potentially directing more funds to diabetes management and device reimbursement. In healthcare resource constraints and emphasis on cost-effectiveness drive the development of affordable devices, promote generic alternatives, and highlight the long-term cost benefits of effective diabetes management through devices.
The increasing awareness of the diabetes problem directs the UK Diabetes Devices market focus toward early detection and prevention and highlighting devices for prediabetes screening, continuous glucose monitoring, and tools for promoting lifestyle changes. As the patient population increases, there is a demand for personalized care, data-driven insights, and remote monitoring solutions, rising patient-physician communication and care coordination.
UK Diabetes Devices Market Segment Analysis
Based on Type, the Blood glucose monitoring systems segment held the largest market share of about 60% in the UK Diabetes Devices Market in 2023. According to the MMR analysis, the segment is further expected to grow at a CAGR of 3.12% during the forecast period. It stands out as the dominant segment within the UK Diabetes Devices Market thanks to its rapid technological advancement and growing adoption of smart devices with data connectivity and integration.
The imperative for accurate blood glucose monitoring fuels continuous innovation in Blood Glucose Monitoring Systems (BGMS) technology.
Developments such as Continuous Glucose Monitoring (CGM) systems, Flash Glucose Monitoring (FGM) devices, and smart technology integration shape the UK Diabetes Devices market. In specific segments:
1. Self-Monitoring Blood Glucose Monitoring Systems (SMBGMS): With the rise of CGM and FGM, SMBGMS persist as the most widely used due to affordability and user-friendliness, fostering a growing UK Diabetes Devices market for associated components.
2. Insulin Delivery Devices: Accurate BGMS data impacts insulin dosing decisions, benefiting insulin pumps with real-time CGM data for precise control, while SMBGMS data guides insulin pen and syringe usage.
3. Digital Health Integration: BGMS data integration with digital health platforms and telehealth services enables remote monitoring, personalized care plans, and increased communication between patients and healthcare providers.
In addition, determining a specific profit for the Blood glucose monitoring systems segment in the UK diabetes devices market is challenging. However, assessing the market size, growth, and profit influencing factors provides insight into its profitability and potential growth.
UK Diabetes Devices Market Scope : Inquire Before Buying
| UK Diabetes Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 800 Mn. |
| Forecast Period 2024 to 2030 CAGR: | 5.96% | Market Size in 2030: | US $ 1200 Mn. |
| Segments Covered: | by Type | Blood glucose monitoring systems Self-monitoring blood glucose monitoring systems Continuous glucose monitoring systems Test strips/Test papers Lancets/Lancing Devices Insulin Delivery Devices Insulin pumps Insulin pens Insulin syringes and needles Diabetes management mobile applications |
|
| by End User | Hospitals & Specialty Clinics Self & Home Care |
||
UK Diabetes Devices Market, Key Players are
1. Magstim (UK)
2. Deltex Medical (UK)
3. Johnson & Johnson
4. DarioHealth
5. Medtronic
6. Philipps Healthcare
7. Dexcom
8. Roche Diabetes Care
9. Medtronic plc
10. Abbott Laboratories
11. Becton, Dickinson and Company (BD)
12. Sanofi
13. Novo Nordisk
14. Ascensia Diabetes Care
15. Insulet Corporation
Frequently Asked Questions:
1. What is the growth rate of Market?
Ans: The Market is growing at a CAGR of 5.96% during forecasting period 2024-2030.
2. What is scope of the Market report?
Ans: Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
3. Who are the key players in Market?
Ans: The important key players in the Market are – Magstim (UK), Deltex Medical (UK), Johnson & Johnson, DarioHealth, Medtronic, Philipps Healthcare, Dexcom, Roche Diabetes Care, Medtronic plc, Abbott Laboratories, Becton, Dickinson and Company (BD), Sanofi, Novo Nordisk, Ascensia Diabetes Care, Insulet Corporation.
4. What is the study period of this Market?
Ans: The UK Diabetes Devices Market is studied from 2023 to 2030.